Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Btk Y753-p , Y759-p , Y1217-p
ChaK1 T1045-p , S1164-p
Hck Y1217-p
Syk Y759-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Btk Y753-p , Y759-p
ChaK1 S1164-p
Fyn Y753-p , Y759-p
Hck Y1217-p
Lck Y753-p , Y759-p , Y1197-p , Y1217-p
Src Y753-p , Y759-p
Syk Y759-p
Phosphatases, in vitro:
PTP1B Y759-p
Regulatory protein:
Btk Y759-p , Y1217-p
FGFR1 Y759-p
ZAP70 Y753-p
Treatment:
A-1769575 Y1217-p
ABBV-105 Y1217-p
acalabrutinib Y753-p , Y759-p , Y1217-p
AdipoRon Y759-p
alpha-IgM Y759-p , Y1217-p
antibody Y753-p , Y759-p , Y1197-p , Y1217-p
BIIB091 Y1217-p
bisindolylmaleimide Y753-p , Y759-p , Y1217-p
collagen Y753-p
compound 1 Y1217-p
compound 2 Y1217-p
compound_C Y759-p
convulxin Y753-p , Y759-p , Y1197-p , Y1217-p
CXCL12 Y759-p , Y1217-p
dasatinib Y759-p , Y1217-p
EGF Y495-p
ephrin_B1 Y1217-p
GDC-0853 Y1217-p
H2O2 Y753-p , Y759-p
ibrutinib Y753-p , Y759-p , Y1217-p
idelalisib Y759-p
IgG Y759-p , Y1217-p
IL-15 Y759-p
IL-2 Y759-p
imatinib Y818-p , Y1245-p , Y1264-p
LFM-A13 Y753-p , Y759-p , Y1217-p
Luxeptinib Y1217-p
LY294002 Y753-p , Y759-p , Y1217-p
okadaic_acid Y759-p
PDGF Y753-p , Y759-p , Y1197-p , Y1217-p
phorbol_ester Y753-p , Y759-p , Y1217-p
pirtobrutinib Y1217-p
PP1 Y753-p , Y759-p , Y1217-p
ristocetin Y753-p , Y759-p
saracatinib Y759-p , Y1217-p
siRNA Y1217-p
SU6656 Y759-p , Y1217-p
TAS5315 Y1217-p
vanadate Y753-p , Y759-p , Y1197-p , Y1217-p
vecabrutinib Y759-p
von_Willebrand_factor Y753-p , Y759-p
wortmannin Y759-p , Y1217-p
zanubrutinib Y1217-p